Ecuador vs Ukraine: Previously treated cases tested for RR-/MDR-TB
Ecuador
97.0%
in 2024
Ukraine
97.0%
in 2024
Ecuador rank
61st
Ukraine rank
61st
Previously treated cases tested for RR-/MDR-TB over time
- Ecuador
- Ukraine
How they compare
Ecuador currently reports 97.0% against 97.0% in Ukraine, a difference of 0.0%.
The two have swapped places 6 times across 10 shared years of data; in 2010 it was Ukraine ahead.
Ecuador ranks 61st and Ukraine ranks 61st of 180 countries.
Ecuador has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Ecuador | Ukraine | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 85.6% | 71.3% | 14.3% | Ecuador |
| 2020s | 97.3% | 97.3% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Ecuador or Ukraine?
- Ecuador, at 97.0% against 97.0% in Ukraine as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Ecuador and Ukraine?
- 0.0%, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and Ukraine?
- 10 years are reported by both, from 2010 to 2024.
- How do Ecuador and Ukraine rank globally for previously treated cases tested for rr-/mdr-tb?
- Ecuador ranks 61st and Ukraine ranks 61st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.